Penny L. Moore

Also affiliated with South African Medical Research Council, University of the Witwatersrand, Centre for the AIDS Programme of Research in South Africa, Institute for Biomedicine, University of Gothenburg, University of KwaZulu-Natal

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 68 papers. Top paper: “SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma”.

SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma

Nature Medicine(2021)10.1038/s41591-021-01285-x

N/A

18.0DataRank · unranked

1273 citations

Frances Ayres, Tandile Hermanus, Mashudu Madzivhandila, Prudence Kgagudi, Brent Oosthuysen +14 more

Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant

New England Journal of Medicine(2021)10.1056/nejmoa2102214

N/A

13.3DataRank · unranked

1321 citations

Vicky L. Baillie, Clare Cutland, Merryn Voysey, Anthonet Koen, Lee Fairlie +46 more

Safety and pharmacokinetics of escalating doses of neutralising monoclonal antibody CAP256V2LS administered with and without VRC07-523LS in HIV-negative women in South Africa (CAPRISA 012B): a phase 1, dose-escalation, randomised controlled trial

The Lancet HIV(2023)10.1016/s2352-3018(23)00003-6

N/A

1.1DataRank · unranked

40 citations

Nigel Garrett, Edmund V. Capparelli, Farzana Osman, Nonhlanhla N. Mkhize, Ishana Harkoo +16 more

T cell responses to SARS-CoV-2 spike cross-recognize Omicron

Nature(2022)10.1038/s41586-022-04460-3

N/A

0.966DataRank · unranked

625 citations

Marius B. Tincho, Amkele Ngomti, Richard Baguma, Ntombi Benede, Akiko Suzuki +42 more

Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants

Science(2021)10.1126/science.abh1766

N/A

0.807DataRank · unranked

216 citations

Tongqing Zhou, Yi Zhang, Eun Sung Yang, Chaim A. Schramm, Wei Shi +53 more

Omicron infection enhances Delta antibody immunity in vaccinated persons

Nature(2022)10.1038/s41586-022-04830-x

N/A

0.675DataRank · unranked

89 citations

Farina Karim, Sandile Cele, Kajal Reedoy, James Emmanuel San, Gila Lustig +52 more

Clinical trials of broadly neutralizing monoclonal antibodies in people living with HIV – a review

AIDS Research and Therapy(2025)10.1186/s12981-025-00734-8

N/A

0.494DataRank · unranked

26 citations

Kayla Pillay, Razia Hassan-Moosa, Bruna P. G. V. Galvão, Wendy A. Burgers, Penny L. Moore +4 more

Hemagglutinin Stalk-Specific Fc-Mediated Functions Are Associated With Protection Against Influenza Illness After Seasonal Influenza Vaccination

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae241

N/A

0.491DataRank · unranked

11 citations

Nisha Dhar, Marta C. Nunes, Florian Krammer, Shabir A. Madhi, Penny L. Moore +2 more

Chinks in the armor of the HIV-1 Envelope glycan shield: Implications for immune escape from anti-glycan broadly neutralizing antibodies

Virology(2017)10.1016/j.virol.2016.10.026

N/A

0.373DataRank · unranked

11 citations

Roux-Cil Ferreira, Reyaaz Davids, Zarinah Sonday, Penny L. Moore, Simon A. Travers +3 more

Antibody class-switching as a strategy to improve HIV-1 neutralization

Trends in Molecular Medicine(2022)10.1016/j.molmed.2022.08.010

N/A

0.373DataRank · unranked

11 citations

Simone I. Richardson, Thandeka Moyo-Gwete, Penny L. Moore, Cathrine Scheepers

Resistance mutations that distinguish HIV-1 envelopes with discordant VRC01 phenotypes from multi-lineage infections in the HVTN703/HPTN081 trial: implications for cross-resistance

Journal of Virology(2025)10.1128/jvi.01730-24

N/A

0.331DataRank · unranked

7 citations

Bronwen E. Lambson, Nonhlanhla N. Mkhize, Chivonne Moodley, Anna Yssel, Thandeka Moyo-Gwete +16 more

Isolation and characterization of IgG3 glycan-targeting antibodies with exceptional cross-reactivity for diverse viral families

PLoS Pathogens(2024)10.1371/journal.ppat.1012499

N/A

0.312DataRank · unranked

7 citations

Andrea R. Shiakolas, Jared Lindenberger, Robert A Richardson, Lindsay E Bass, Maggie Barr +29 more

Development of LIBRA-seq for the guinea pig model system as a tool for the evaluation of antibody responses to multivalent HIV-1 vaccines

Journal of Virology(2023)10.1128/jvi.01478-23

N/A

0.251DataRank · unranked

3 citations

Nagarajan Raju, Prudence Kgagudi, Nelia P. Manamela, Alexandra A. Abu-Shmais, Kathryn R. Gripenstraw +10 more

Longitudinal analysis of subtype C envelope tropism for memory CD4+ T cell subsets over the first 3 years of untreated HIV-1 infection

Retrovirology(2020)10.1186/s12977-020-00532-2

N/A

0.208DataRank · unranked

3 citations

Paul R. Gorry, Carolin Tumpach, Jingling Zhou, Ashanti Dantanarayana, Judy Chang +10 more

Extended safety and tolerability of subcutaneous CAP256V2LS and VRC07-523LS in HIV-negative women: study protocol for the randomised, placebo-controlled double-blinded, phase 2 CAPRISA 012C trial

BMJ Open(2023)10.1136/bmjopen-2023-076843

N/A

0.104DataRank · unranked

1 citations

Nigel Garrett, Disebo Potloane, Izukanji Sikazwe, Edmund V. Capparelli, Ishana Harkoo +22 more

Dependence on a variable residue limits the breadth of an HIV MPER neutralizing antibody, despite convergent evolution with broadly neutralizing antibodies

PLoS Pathogens(2022)10.1371/journal.ppat.1010450

N/A

0.104DataRank · unranked

1 citations

Prudence Kgagudi, Nonkululeko Mzindle, Elin S. Gray, Thandeka Moyo-Gwete, Bronwen E. Lambson +7 more

Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection

medRxiv(2023)10.1101/2023.03.15.23287288

N/A

0.104DataRank · unranked

1 citations

Simone I. Richardson, Roanne Keeton, Tandile Hermanus, Holly Spencer, Nelia P. Manamela +20 more

Safety and efficacy of the ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine against the B.1.351 variant in South Africa

medRxiv(2021)10.1101/2021.02.10.21251247

N/A

0DataRank · unranked

122 citations

Vicky L. Baillie, Clare Cutland, Merryn Voysey, Anthonet Koen, Lee Fairlie +48 more

SARS-CoV-2 501Y.V2 (B.1.351) elicits cross-reactive neutralizing antibodies

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.03.06.434193

N/A

0DataRank · unranked

39 citations

Mashudu Madzivhandila, Zanele Makhado, Frances Ayres, Donald Mhlanga, Brent Oosthuysen +22 more

SARS-CoV-2 evolved during advanced HIV disease immunosuppression has Beta-like escape of vaccine and Delta infection elicited immunity

medRxiv(2021)10.1101/2021.09.14.21263564

N/A

0DataRank · unranked

23 citations

Farina Karim, Gila Lustig, James Emmanuel San, Tandile Hermanus, Houriiyah Tegally +24 more

Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant dependent manner

medRxiv(2021)10.1101/2021.07.24.21261037

N/A

0DataRank · unranked

14 citations

Simone I. Richardson, Thandeka Moyo-Gwete, Tandile Hermanus, Marius B. Tincho, Ntombi Benede +30 more

Loss of recognition of SARS-CoV-2 B.1.351 variant spike epitopes but overall preservation of T cell immunity

medRxiv(2021)10.1101/2021.06.03.21258307

N/A

0DataRank · unranked

10 citations

Roanne Keeton, Thandeka Moyo-Gwete, Tandile Hermanus, Prudence Kgagudi, Richard Baguma +21 more

Modified Adenovirus Prime-Protein Boost Clade C HIV Vaccine Strategy Results in Reduced Viral DNA in Blood and Tissues Following Tier 2 SHIV Challenge

Frontiers in Immunology(2021)10.3389/fimmu.2020.626464

N/A

0DataRank · unranked

6 citations

Lo Vang, Jason Mendy, Philip Barnette, David A. Spencer, Jason S. Reed +17 more

SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape

Cell Host & Microbe(2022)10.1016/j.chom.2022.01.005

N/A

0DataRank · unranked

241 citations

Farina Karim, Gila Lustig, James Emmanuel San, Tandile Hermanus, Houriiyah Tegally +23 more

The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines

mBio(2022)10.1128/mbio.02979-21

N/A

0DataRank · unranked

202 citations

Jeremy P. Kamil, Benhur Lee, Penny L. Moore, Thomas F. Schulz, Alexander Muik +4 more

Escape from recognition of SARS-CoV-2 variant spike epitopes but overall preservation of T cell immunity

Science Translational Medicine(2022)10.1126/scitranslmed.abj6824

N/A

0DataRank · unranked

126 citations

Roanne Keeton, Thandeka Moyo-Gwete, Tandile Hermanus, Prudence Kgagudi, Richard Baguma +23 more

Combinations of Single Chain Variable Fragments From HIV Broadly Neutralizing Antibodies Demonstrate High Potency and Breadth

Frontiers in Immunology(2021)10.3389/fimmu.2021.734110

N/A

0DataRank · unranked

8 citations

Kshitij Wagh, Penny L. Moore, Lynn Morris, Rebecca T. van Dorsten

Emergence and phenotypic characterization of the global SARS-CoV-2 C.1.2 lineage

Nature Communications(2022)10.1038/s41467-022-29579-9

N/A

0DataRank · unranked

38 citations

Josie Everatt, Daniel G. Amoako, Houriiyah Tegally, Constantinos Kurt Wibmer, Anele Mnguni +40 more

Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac041

N/A

0DataRank · unranked

36 citations

Nigel Garrett, Edmund V. Capparelli, Farzana Osman, Ishana Harkoo, Nonhlanhla Yende‐Zuma +17 more

Convalescent plasma in the treatment of moderate to severe COVID-19 pneumonia: a randomized controlled trial (PROTECT-Patient Trial)

Scientific Reports(2022)10.1038/s41598-022-06221-8

N/A

0DataRank · unranked

33 citations

Tanya Nadia Glatt, Marion Vermeulen, Francesca Little, Ronél Swanevelder, Claire L. Barrett +25 more

Enhanced neutralization potency of an identical HIV neutralizing antibody expressed as different isotypes is achieved through genetically distinct mechanisms

Scientific Reports(2022)10.1038/s41598-022-20141-7

N/A

0DataRank · unranked

14 citations

Cathrine Scheepers, Zanele Makhado, Prudence Kgagudi, Nonkululeko Mzindle, Rutendo Ziki +8 more

ADCC-mediating non-neutralizing antibodies can exert immune pressure in early HIV-1 infection

PLoS Pathogens(2021)10.1371/journal.ppat.1010046

N/A

0DataRank · unranked

16 citations

Gama Bandawe, Jie Zheng, Jennifer Jones, Melissa-Rose Abrahams, Valerie Bekker +10 more

Complementary Roles of Antibody Heavy and Light Chain Somatic Hypermutation in Conferring Breadth and Potency to the HIV-1-Specific CAP256-VRC26 bNAb Lineage

Journal of Virology(2022)10.1128/jvi.00270-22

N/A

0DataRank · unranked

1 citations

Kevin Wiehe, Lynn Morris, Penny L. Moore, David Sacks

Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivity

Journal of Virology(2025)10.1128/jvi.01256-25

N/A

0DataRank · unranked

0 citations

Xiaoying Shen, Alexandra A. Abu-Shmais, Perry T. Wasdin, Katarzyna Janowska, Robert J. Edwards +37 more

Enhanced neutralization potency of an identical HIV neutralizing antibody expressed as different isotypes is achieved through genetically distinct mechanisms

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.08.17.504233

N/A

0DataRank · unranked

2 citations

Cathrine Scheepers, Zanele Makhado, Prudence Kgagudi, Nonkululeko Mzindle, Rutendo Ziki +8 more

Dependence on a variable residue limits the breadth of an HIV MPER neutralizing antibody, despite convergent evolution with broadly neutralizing antibodies

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.18.484856

N/A

0DataRank · unranked

1 citations

Prudence Kgagudi, Nonkululeko Mzindle, Elin S. Gray, Thandeka Moyo-Gwete, Bronwen E. Lambson +7 more

Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials

PLoS Pathogens(2023)10.1371/journal.ppat.1011469

N/A

0DataRank · unranked

56 citations

Anna Yssel, Haajira Kaldine, Rebecca T. van Dorsten, Amanda S. Woodward Davis, Nicolas Beaume +35 more

Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant-dependent manner

Cell Host & Microbe(2021)10.1016/j.chom.2021.10.003

N/A

0DataRank · unranked

117 citations

Simone I. Richardson, Thandeka Moyo-Gwete, Tandile Hermanus, Marius B. Tincho, Ntombi Benede +30 more

Distinct T cell polyfunctional profile in SARS-CoV-2 seronegative children associated with endemic human coronavirus cross-reactivity

iScience(2023)10.1016/j.isci.2023.108728

N/A

0DataRank · unranked

9 citations

Marius B. Tincho, Avril Walters, Vennesa Subbiah, Amkele Ngomti, Richard Baguma +26 more

Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection

PLoS Pathogens(2023)10.1371/journal.ppat.1011772

N/A

0DataRank · unranked

5 citations

Simone I. Richardson, Roanne Keeton, Tandile Hermanus, Holly Spencer, Nelia P. Manamela +20 more

Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization

Nature(2021)10.1038/d41586-021-03824-5

N/A

0DataRank · unranked

188 citations

Laurelle Jackson, David S. Khoury, Khadija Khan, Thandeka Moyo-Gwete, Houriiyah Tegally +29 more

Needle-Free Devices and CpG-Adjuvanted DNA Improve Anti-HIV Antibody Responses of Both DNA and Modified Vaccinia Ankara-Vectored Candidate Vaccines

Vaccines(2023)10.3390/vaccines11020376

N/A

0DataRank · unranked

3 citations

Michiel T. van Diepen, Nicola Douglass, Tandile Hermanus, Penny L. Moore, Anna‐Lise Williamson +1 more

Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization

Nature(2021)10.1038/s41586-021-04387-1

N/A

0DataRank · unranked

1193 citations

Laurelle Jackson, David S. Khoury, Khadija Khan, Thandeka Moyo-Gwete, Houriiyah Tegally +58 more

Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants

medRxiv(2023)10.1101/2023.11.20.23298785

N/A

0DataRank · unranked

5 citations

Jinal N. Bhiman, Yashica Ganga, Shobna Sawry, Frances Ayres, Richard Baguma +51 more

Rapid Induction of Multifunctional Antibodies in Rabbits and Macaques by Clade C HIV-1 CAP257 Envelopes Circulating During Epitope-Specific Neutralization Breadth Development

Frontiers in Immunology(2020)10.3389/fimmu.2020.00984

N/A

0DataRank · unranked

11 citations

Constantinos Kurt Wibmer, Molati Nonyane, Jason S. Reed, D. Noah Sather, David A. Spencer +11 more

Distinct T cell functional profiles in SARS-CoV-2 seropositive and seronegative children associated with endemic human coronavirus cross-reactivity

medRxiv(2023)10.1101/2023.05.16.23290059

N/A

0DataRank · unranked

1 citations

Marius B. Tincho, Avril Walters, Vennesa Subbiah, Amkele Ngomti, Richard Baguma +18 more

Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials

UNC Libraries(2023)10.17615/nx73-wv26

N/A

0DataRank · unranked

0 citations

John Hural, Ruwayhida Thebus, Amanda Eaton, Shelly Karuna, Myron S. Cohen +35 more

Development of LIBRA-seq for the Guinea Pig Model System as a Tool for the Evaluation of Antibody Responses to Multivalent HIV-1 Vaccines

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.09.25.559382

N/A

0DataRank · unranked

0 citations

Nagarajan Raju, Prudence Kgagudi, Nelia P. Manamela, Alexandra A. Abu-Shmais, Kathryn R. Gripenstraw +10 more

SARS-CoV-2 correlates of protection from infection against variants of concern

Nature Medicine(2024)10.1038/s41591-024-03131-2

N/A

0DataRank · unranked

39 citations

Jinal N. Bhiman, Stefano Tempia, Jackie Kleynhans, Vimbai Sharon Madzorera, Qiniso Mkhize +25 more

Evolution of an HIV glycan–dependent broadly neutralizing antibody epitope through immune escape

UNC Libraries(2020)10.17615/e8bk-6082

N/A

0DataRank · unranked

0 citations

Quarraisha Abdool Karim, Bronwen E. Lambson, Penny L. Moore, Salim S. Abdool Karim, C Kurt Wibmer +15 more

Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants

PLOS Global Public Health(2024)10.1371/journal.pgph.0002703

N/A

0DataRank · unranked

12 citations

Jinal N. Bhiman, Yashica Ganga, Shobna Sawry, Frances Ayres, Richard Baguma +51 more

Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization

UNC Libraries(2020)10.17615/2f0r-b813

N/A

0DataRank · unranked

0 citations

Michael S. Seaman, David C. Montefiori, Kshitij Wagh, Glenda Gray, Feng Gao +33 more

Safety and pharmacokinetics of subcutaneous administration of broadly neutralizing anti-HIV-1 monoclonal antibodies (bNAbs), given to HIV-1 exposed, uninfected neonates and infants: study protocol for a phase I trial

BMC Infectious Diseases(2024)10.1186/s12879-024-09588-3

N/A

0DataRank · unranked

4 citations

Trisha Ramraj, Logashvari Naidoo, Brodie Daniels, Masefetsane Matlou, Terusha Chetty +28 more

Aberrant innate immune profile associated with COVID-19 mortality in Pretoria, South Africa

Clinical Immunology(2024)10.1016/j.clim.2024.110323

N/A

0DataRank · unranked

4 citations

Zelda de Beer, Helen C. Steel, Ronald Anderson, Andries Masenge, Penny L. Moore +6 more

Effect of HIV Envelope Vaccination on the Subsequent Antibody Response to HIV Infection

mSphere(2020)10.1128/msphere.00738-19

N/A

0DataRank · unranked

9 citations

Nonhlanhla N. Mkhize, Michael T. Yin, Michael C. Keefer, David C. Montefiori, Georgia D. Tomaras +13 more

Antibody Isotype Switching as a Mechanism to Counter HIV Neutralization Escape

Cell Reports(2020)10.1016/j.celrep.2020.108430

N/A

0DataRank · unranked

26 citations

Valerie Bekker, Colin Anthony, Simone I. Richardson, Brent Oosthuysen, Thandeka Moyo-Gwete +16 more

Rare twin cysteine residues in the HIV-1 envelope variable region 1 link to neutralization escape and breadth development

Cell Host & Microbe(2025)10.1016/j.chom.2025.01.004

N/A

0DataRank · unranked

3 citations

Marius Zeeb, Peter Rusert, Chloé Pasin, Jennifer L. Mamrosh, Samuel Mundia Kariuki +33 more

Population pharmacokinetics of weight-based compared with fixed dosing of CAP256V2LS, a broadly neutralizing antibody for HIV prevention in women

Journal of Antimicrobial Chemotherapy(2025)10.1093/jac/dkaf181

N/A

0DataRank · unranked

1 citations

Martin Béliveau, Roberto Heredia‐Ortiz, Farzana Osman, Marothi Letsoalo, Nigel Garrett +13 more

Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.07.01.659979

N/A

0DataRank · unranked

1 citations

Chivonne Moodley, Craig A. Magaret, Elena Giorgi, Morgane Rolland, Dylan H. Westfall +43 more

Rapid loss of activity but not serum concentration in a passive infusion clinical trial of an HIV neutralizing antibody

medRxiv(2025)10.1101/2025.09.04.25334949

N/A

0DataRank · unranked

1 citations

Nonhlanhla N. Mkhize, Leonid Serebryannyy, Tandile Hermanus, Prudence Kgagudi, Haajira Kaldine +15 more

VRC01 Selects Rare HIV Escape Mutations After Acquisition in Antibody-Mediated Prevention Trials

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.10.29.685411

N/A

0DataRank · unranked

1 citations

Lyle Curry, Nonhlanhla N. Mkhize, Elena Giorgi, Craig A. Magaret, Bronwen E. Lambson +44 more

Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivity

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.01.17.633475

N/A

0DataRank · unranked

0 citations

Xiaoying Shen, Alexandra A. Abu-Shmais, Perry T. Wasdin, Katarzyna Janowska, Robert J. Edwards +28 more

Heterologous Immunization with Improved HIV-1 Subtype C Vaccines Elicit Autologous Tier 2 Neutralizing Antibodies with Rapid Viral Replication Control After SHIV Challenge

Viruses(2025)10.3390/v17020277

N/A

0DataRank · unranked

0 citations

Rosamund Chapman, Alana Keyser, Craig H. Adams, Kealan Benn, Michiel T. van Diepen +6 more

BRAVE: a highly accurate method for predicting HIV-1 antibody resistance using large language models for proteins

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.07.28.667234

N/A

0DataRank · unranked

0 citations

Tatsiana Bylund, Sijy O’Dell, Emily Tourtellott, Krisha McKee, Stephen D. Schmidt +6 more

Plasmodium falciparum Parasitemia Does Not Diminish Neutralizing Antibody Responses After mRNA COVID-19 Booster Vaccination in HIV-infected Adults

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf398

N/A

0DataRank · unranked

0 citations

Millicent Achola, Jack Hutter, Grace Mboya, Walter Otieno, Jia Jin Kee +16 more

Neutralizing antibody responses over time in a demographically and clinically diverse cohort of individuals recovered from SARS-CoV-2 acquisition in Africa: A cohort study

PLOS Global Public Health(2025)10.1371/journal.pgph.0005156

N/A

0DataRank · unranked

0 citations

Shuying Sue Li, Jiani Hu, Samuel T. Robinson, Zaheer Hoosain, Nigel Garrett +16 more

SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection

medRxiv(2021)10.1101/2021.12.08.21267417

N/A

0DataRank · unranked

366 citations

Laurelle Jackson, David S. Khoury, Khadija Khan, Thandeka Moyo-Gwete, Houriiyah Tegally +29 more

SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.01.18.427166

N/A

0DataRank · unranked

310 citations

Frances Ayres, Tandile Hermanus, Mashudu Madzivhandila, Prudence Kgagudi, Brent Oosthuysen +14 more